• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Key mechanism identified in brain tumor growth

Bioengineer by Bioengineer
April 25, 2016
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Glioblastoma is the most aggressive type of brain tumor in adults. Unfortunately, there are no effective treatments for the disease. On average, patients succumb just 16 months after diagnosis.

"To develop better treatments, we need to gain a better understanding of what is really going on inside these tumors," says lead author Arezu Jahani-Asl, Assistant Professor of Medicine at McGill and neuroscientist at the Jewish General Hospital's Lady Davis Institute for Medical Research in Montreal.

A missing piece of the puzzle

Researchers had known for some time that a mutant variation of another gene, known as EGFRvIII, produces a major tumor-forming protein in glioblastoma. But treatments aimed at disabling EGFRvIII in these patients have been disappointingly ineffective.

Some piece of the molecular puzzle must have been missing.

So Jahani-Asl went hunting for it in tissue samples from glioblastoma patients as she was pursuing a postdoctoral fellowship in the laboratories of Azad Bonni at Harvard Medical School and Washington University School of Medicine and Michael Rudnicki at The Ottawa Hospital and the University of Ottawa. The researchers discovered that the OSMR gene was very active in glioblastoma cells. What's more, by using existing cancer genetic and clinical databases they found that the more active this gene was, the shorter the patient's life span.

The research team then studied human brain tumor stem cells taken from glioblastoma patients. These cells are normally able to proliferate and form new tumors when injected into laboratory mice. To the researchers' surprise, however, they found that when they knock down the gene for OSMR in glioblastoma cells and inject these cells in mouse, they lose their ability to form tumors. "It means that this protein is a key piece of the puzzle," says Rudnicki, senior co-corresponding author of the study.

The researchers concluded that these two genes, OSMR and EGFRvIII, conspire to promote tumor growth by making what's known as a "feed forward" mechanism: when OSMR produces its protein, that signals EGFRvIII to rev up and produce its tumor-forming protein.

So disable OSMR and you disable EGFRvIII.

Potential target for treatments

"The discovery has important clinical implications," says Bonni, senior co-corresponding author. "It provides a new therapeutic avenue for treating this devastating disease, though developing any effective therapy targeting human patients could be years of work."

Jahani-Asl is now developing antibodies and small molecules designed to inhibit the OSMR protein or its interaction with EGFRvIII — a step toward the ultimate goal of finding ways to treat these tumors. "If we find that they can reverse tumor formation in rodent models," she says, "we will be equipped to adapt those techniques for testing in patients."

###

Funding for the research was provided by the U.S. National Institutes for Health, the Canadian Institutes for Health Research, the Mathers Foundation, and the Canada Research Chairs program.

"Control of glioblastoma tumorigenesis by feed-forward cytokine signaling," Arezu Jahani-Asl et al, Nature Neuroscience, published online April 25, 2016.

DOI: 10.1038/nn.4295

Media Contact

Chris Chipello
[email protected]
514-398-4201
@McGillU

http://www.mcgill.ca

The post Key mechanism identified in brain tumor growth appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

Vismodegib Treats Facial Basal Cell Carcinoma

October 6, 2025

AI Predicts Colorectal Cancer Toxicity: Race, Aging Effects

October 6, 2025

SLN Biopsy and Prognosis: HER2-Low vs Zero

October 6, 2025

High Sodium Intake Fuels Global Stomach Cancer

October 6, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    95 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    93 shares
    Share 37 Tweet 23
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    73 shares
    Share 29 Tweet 18
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Vismodegib Treats Facial Basal Cell Carcinoma

Engaging Family Caregivers in Veterans Health Research

New Canadian Study Uncovers HIV Reservoirs Throughout the Body

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.